{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:12:52Z","timestamp":1777896772048,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jocn.2020.09.001","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T07:38:39Z","timestamp":1601019519000},"page":"47-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Sustained clinical improvement of Parkinson\u2019s disease in two patients with facially-transplanted adipose-derived stromal vascular fraction cells"],"prefix":"10.1016","volume":"81","author":[{"given":"Michael","family":"Carstens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihtsham","family":"Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Martinez-Cerrato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severiano","family":"Dos-Anjos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Bertram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2020.09.001_b0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.stem.2017.09.014","article-title":"Human trials of stem cell-derived dopamine neurons for Parkinson\u2019s disease: dawn of a new era","volume":"21","author":"Barker","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jocn.2020.09.001_b0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000355261","article-title":"The therapeutic effects of human adipose-derived stem cells in alzheimer's disease mouse models","volume":"13","author":"Chang","year":"2014","journal-title":"Neurodegenerative Diseases"},{"key":"10.1016\/j.jocn.2020.09.001_b0015","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.neurobiolaging.2015.06.022","article-title":"Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson's disease","volume":"36","author":"Choi","year":"2015","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.jocn.2020.09.001_b0020","doi-asserted-by":"crossref","unstructured":"O. Lindvall Treatment of Parkinson's disease using cell transplantation. Philosophical transactions of the Royal Society of London Series B Biological sciences. 2015;370:20140370-.","DOI":"10.1098\/rstb.2014.0370"},{"key":"10.1016\/j.jocn.2020.09.001_b0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J Orthop Res"},{"key":"10.1016\/j.jocn.2020.09.001_b0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2008.03.002","article-title":"Mesenchymal stem cells: revisiting history, concepts, and assays","volume":"2","author":"Bianco","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jocn.2020.09.001_b0035","doi-asserted-by":"crossref","unstructured":"Murray IR, P\u00e9ault B. Q&A: Mesenchymal stem cells - where do they come from and is it important? BMC Biol. 2015;13:99-.","DOI":"10.1186\/s12915-015-0212-7"},{"key":"10.1016\/j.jocn.2020.09.001_b0040","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Mol Biol Cell."},{"key":"10.1016\/j.jocn.2020.09.001_b0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cps.2014.12.010","article-title":"Adipose tissue and stem\/progenitor cells: discovery and development","volume":"42","author":"Kapur","year":"2015","journal-title":"Clin Plast Surg"},{"key":"10.1016\/j.jocn.2020.09.001_b0050","series-title":"3rd","first-page":"295","article-title":"Principles of regenerative medicine","author":"Brown","year":"2018"},{"key":"10.1016\/j.jocn.2020.09.001_b0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","volume":"15","author":"Bourin","year":"2013","journal-title":"Cytotherapy."},{"key":"10.1016\/j.jocn.2020.09.001_b0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/ten.tec.2016.0377","article-title":"Isolation of adipose-derived stromal vascular fraction cells using a novel point-of-care device: cell characterization and review of the literature","volume":"23","author":"Brown","year":"2017","journal-title":"Tissue Eng Part C: Methods."},{"key":"10.1016\/j.jocn.2020.09.001_b0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","article-title":"The MSC: an injury drugstore","volume":"9","author":"Caplan Arnold","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jocn.2020.09.001_b0070","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bjps.2015.10.015","article-title":"Stromal vascular fraction: A regenerative reality? Part 1: Current concepts and review of the literature","volume":"69","author":"Nguyen","year":"2016","journal-title":"J Plastic, Reconstructive & Aesthetic Surgery."},{"key":"10.1016\/j.jocn.2020.09.001_b0075","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bjps.2015.10.014","article-title":"Stromal vascular fraction: A regenerative reality? Part 2: Mechanisms of regenerative action","volume":"69","author":"Guo","year":"2016","journal-title":"Journal of Plastic, Reconstructive & Aesthetic Surgery."},{"key":"10.1016\/j.jocn.2020.09.001_b0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.scr.2016.12.001","article-title":"Non-reconstructable peripheral vascular disease of the lower extremity in ten patients treated with adipose-derived stromal vascular fraction cells","volume":"18","author":"Carstens","year":"2017","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jocn.2020.09.001_b0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4252\/wjsc.v8.i3.73","article-title":"Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?","volume":"8","author":"De Becker","year":"2016","journal-title":"World J Stem Cells."},{"key":"10.1016\/j.jocn.2020.09.001_b0090","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/342968","article-title":"Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy","volume":"2012","author":"Kang","year":"2012","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.jocn.2020.09.001_b0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cbin.10378","article-title":"Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy","volume":"39","author":"Naderi-Meshkin","year":"2015","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jocn.2020.09.001_b0100","doi-asserted-by":"crossref","unstructured":"Tolhurst DE, Carstens MH, Greco RJ, Hurwitz DJ. The surgical anatomy of the scalp. Plastic and reconstructive surgery. 1991;87:603-12; discussion 13-4.","DOI":"10.1097\/00006534-199104000-00001"},{"key":"10.1016\/j.jocn.2020.09.001_b0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.aanat.2018.11.004","article-title":"Histological, SEM and three-dimensional analysis of the midfacial SMAS \u2014 New morphological insights","volume":"222","author":"Sandulescu","year":"2019","journal-title":"Annals of Anatomy - Anatomischer Anzeiger."},{"key":"10.1016\/j.jocn.2020.09.001_b0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cps.2019.06.007","article-title":"Facial Anatomy for Filler Injection: The Superficial Musculoaponeurotic System (SMAS) Is Not Just for Facelifting","volume":"46","author":"Surek","year":"2019","journal-title":"Clin Plast Surg"},{"key":"10.1016\/j.jocn.2020.09.001_b0115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0963689718754561","article-title":"The Route by Which Intranasally Delivered Stem Cells Enter the Central Nervous System","volume":"27","author":"Galeano","year":"2018","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jocn.2020.09.001_b0120","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Movement Disord."},{"key":"10.1016\/j.jocn.2020.09.001_b0125","first-page":"3353","article-title":"Differentiation of human adipose-derived stem cells into neuron-like cells by Radix Angelicae Sinensis","volume":"8","author":"Wang","year":"2013","journal-title":"Neural Regen Res."},{"key":"10.1016\/j.jocn.2020.09.001_b0130","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/ejn.12459","article-title":"Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease","volume":"39","author":"Stott","year":"2014","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jocn.2020.09.001_b0135","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/rme.15.17","article-title":"Adipose-derived human mesenchymal stem cells induce long-term neurogenic and anti-inflammatory effects and improve cognitive but not motor performance in a rat model of Parkinson's disease","volume":"10","author":"Schwerk","year":"2015","journal-title":"Regenerative Medicine."},{"key":"10.1016\/j.jocn.2020.09.001_b0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev-physiol-021014-071641","article-title":"Exosomes: Vehicles of Intercellular Signaling, Biomarkers, and Vectors of Cell Therapy","volume":"77","author":"Kourembanas","year":"2015","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jocn.2020.09.001_b0145","series-title":"Proceedings of the National Academy of Sciences","article-title":"Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus","author":"Long","year":"20171143536"},{"key":"10.1016\/j.jocn.2020.09.001_b0150","doi-asserted-by":"crossref","unstructured":"Das M, Mayilsamy K, Mohapatra Shyam S, Mohapatra S. Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects. Reviews in the neurosciences2019. p. 839.","DOI":"10.1515\/revneuro-2019-0002"},{"key":"10.1016\/j.jocn.2020.09.001_b0155","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/scd.2010.0466","article-title":"Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans","volume":"20","author":"Ra","year":"2011","journal-title":"Stem Cells Dev."}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820314788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820314788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:23:22Z","timestamp":1760822602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586820314788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":31,"alternative-id":["S0967586820314788"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2020.09.001","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained clinical improvement of Parkinson\u2019s disease in two patients with facially-transplanted adipose-derived stromal vascular fraction cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2020.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}